Please login to the form below

Not currently logged in
Email:
Password:

Combination therapies

This page shows the latest Combination therapies news and features for those working in and with pharma, biotech and healthcare.

Janssen scores another expansion for new Darzalex combination in the US

Janssen scores another expansion for new Darzalex combination in the US

Myeloma med approved in combination with Amgen's Kyprolis. Johnson &Johnson’s Janssen unit has scored approval from the US Food and Drug Administration (FDA) for a new regimen of its ... Janssen has been expanding the use of Darzalex with a number of

Latest news

More from news
Approximately 0 fully matching, plus 103 partially matching documents found.

Latest Intelligence

  • A snapshot of… Enterprise Therapeutics A snapshot of… Enterprise Therapeutics

    The company envisages that its drugs will be effective as monotherapies and in combination with other CF therapies including CFTR modulators. ... We are fortunate that Enterprise is well positioned and funded by a combination of private investors and the

  • Detecting Alzheimer’s ahead of a cure Detecting Alzheimer’s ahead of a cure

    Many are now coming to the same conclusion: that a combination of different therapies and detection methods could be the answer to fighting Alzheimer’s. ... Alzheimer’s Research UK is launching head first into the fight, with a new drive towards

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    disease. Targeting tau. Tau is among the beneficiaries of the broader focus and emerging interest in combination therapies. ... These mechanisms may be complementary. “We think combination therapies between. antibodies and small molecules make a lot of

  • Combining therapies and combining research Combining therapies and combining research

    create new super-resistant combination therapies. ... This crucial observation was followed by combination therapies for other major disease areas such as AIDS and cancer.

  • Combined immunotherapies – potential and pitfalls Combined immunotherapies – potential and pitfalls

    Efforts to prevent resistance are also driving interest in combination therapies, said Matthew Galsky, MD, professor of medicine, haematology and medical oncology, Mount Sinai Hospital in New York. ... The risk of autoimmune responses or toxicities, and

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics